Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quality metrics for stem cell-derived cardiac myocytes.

Stem cell reports - 11 Mar 2014

Sheehy Sean P, Pasqualini Francesco, Grosberg Anna, Park Sung Jin, Aratyn-Schaus Yvonne, Parker Kevin Kit

Abstract excerpt

Advances in stem cell manufacturing methods have made it possible to produce stem cell-derived cardiac myocytes at industrial scales for in vitro muscle physiology research purposes. Although FDA-mandated quality assurance metrics address safety issues in the manufacture of stem cell-based products, no standardized guidelines currently exist for the evaluation of stem cell-derived myocyte functionality. As a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Culture Techniques
Share to Electrophysiological Phenomena

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Embryonic Stem Cells

Share to Extracellular Matrix

Share to Myocardial Contraction

Share to Myocytes, Cardiac

Share to Myofibrils

Share to Sarcomeres

Source

Open in PubMed Open full text

Identifiers

PMID: 24672752
DOI: 10.1016/j.stemcr.2014.01.015
PMCID: PMC3964283

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quality metrics for stem cell-derived cardiac myocytes.PMID 24672752Read ↗

Advances in induced pluripotent stem cell‐derived cardiac myocytes: technological breakthroughs, key discoveries and new applicationsSemantic proximity Read ↗

Are these cardiomyocytes? Protocol development reveals impact of sample preparation on the accuracy of identifying cardiomyocytes by flow cytometrySemantic proximity Read ↗

Human iPSC-engineered cardiac tissue platform faithfully models important cardiac physiology.Semantic proximity Read ↗

Engineered Microenvironments for Maturation of Stem Cell Derived Cardiac MyocytesSemantic proximity Read ↗

Phenotypic assays for analyses of pluripotent stem cell-derived cardiomyocytes.Semantic proximity Read ↗

Modelling sarcomeric cardiomyopathies with human cardiomyocytes derived from induced pluripotent stem cellsSemantic proximity Read ↗

Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cellsSemantic proximity Read ↗

Stem cell therapy for heart failure: Ensuring regenerative proficiency.Semantic proximity Read ↗

Evaluation of Batch Variations in Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes from 2 Major SuppliersSemantic proximity Read ↗

Identifying Features of Cardiac Disease Phenotypes Based on Mechanical Function in a Catecholaminergic Polymorphic Ventricular Tachycardia ModelSemantic proximity Read ↗

Noninvasive analysis of contractility during identical maturations revealed two phenotypes in ventricular but not in atrial iPSC-CM.Semantic proximity Read ↗

Cardiac Non-myocyte Cells Show Enhanced Pharmacological Function Suggestive of Contractile Maturity in Stem Cell Derived Cardiomyocyte Microtissues.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.